Breaking the “Black Box” in Bioprocessing
May 14, 2026
Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development
9 min read
False
Advertisement
Bioprocessing
This Week’s Biopharma News: Amgen Deepens US Manufacturing Push
May 12, 2026
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
6 min read
Merck Expands Protein A Capabilities with JSR Chromatography Acquisition
April 16, 2026
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
AI and the Future of Bioprocess Labs
March 24, 2026
Modular automation with human oversight across laboratory and manufacturing scales
2 min read
Machine Learning Enables Real-Time Bioprocess Optimization
March 23, 2026
An integrated machine learning framework adapts culture conditions during long perfusion runs
2 min read
Repurposed Drugs Reshape Pricing Debate
March 19, 2026
Study models sustainable pricing for repurposed bevacizumab
2 min read
Mining the Literature for Bioprocess Gains
March 10, 2026
Automated text extraction connects culture conditions, purification steps, and productivity metrics
2 min read
A Simpler, Smarter CHO Strategy for High-Quality Bispecifics
By Yiting Lim
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
Manufacturability and the Winners in Advanced Therapies
By Stephanie Vine
January 13, 2026
Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.
7 min read
